Company Filing History:
Years Active: 2018
Title: An Insight into the Innovations of Daniel Basting
Introduction
Daniel Basting is an influential figure in the field of pharmaceuticals, residing in Köln, Germany. With a significant contribution to medical advancements, he holds a total of two patents that reflect his innovative spirit and commitment to improving healthcare.
Latest Patents
Among Daniel Basting's latest achievements are two key patents. The first patent involves compounds related to substituted N-(phenyl-heteroaryl)-3-acetylamino-benzamides and N-[3-(acetylamino)phenyl]-phenyl-heteroaryl-carboxamides, which are designed for the treatment or prophylaxis of diseases such as cancer. This invention details the structures and methods for creating these pharmaceutical compositions, emphasizing the potential for significant therapeutic interventions.
The second patent pertains to amido-substituted azole compounds, which serve as inhibitors of TNKS1 and/or TNKS2. These compounds are aimed at treating neoplasms, showcasing their utility either as a standalone agent or in combination with other active ingredients.
Career Highlights
Daniel Basting works at Bayer Pharma Aktiengesellschaft, a leading company in the pharmaceutical sector. His role involves extensive research and development, focusing on creating effective therapies for complex diseases. His contributions not only underline his expertise but also enhance Bayer Pharma's reputation as an innovative force in the industry.
Collaborations
In his professional journey, Daniel collaborates with esteemed colleagues such as Eckhard Bender and Stefan Golz. These partnerships reflect a dynamic approach to research, allowing for the exchange of ideas and expertise that propel their projects forward.
Conclusion
Daniel Basting is a notable inventor whose work exemplifies the intersection of innovation and healthcare. With his patents focusing on critical therapeutic compounds, he continues to make strides in improving patient outcomes and advancing medical science. His dedication to research and collaboration within Bayer Pharma underscores the essential role inventors play in shaping the future of pharmaceuticals.